It does not replace lifestyle interventions, glucose monitoring, or routine follow-up
Overall, 140 participants (32.1%) reported lifetime use of semaglutide, tirzepatide, dulaglutide, liraglutide, or exenatide, used for either diabetes management or weight loss, while 96 (22%) reported current use
Tesamorelins trans-3-hexenoic acid modification at the N-terminus protects against DPP-IV cleavage, extending its effective half-life compared to native GHRH
People with a personal or family history of medullary thyroid carcinoma, MEN 2, or a prior serious hypersensitivity reaction to the specific medication should not use Wegovy or Zepbound
Its a common side effect, but there are ways to find relief, even while continuing to take the medication
reports consulting/speaker honoraria from Abbott Laboratories, AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Novartis, Menarini-Ricerche, Novo Nordisk, Pfizer, Roche Diagnostics and Sanofi, along with grants paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis and Roche Diagnostics
